<p>Herriot Tabuteau, Chief Executive Officer and Director of Axsome Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-308354), on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

AXSM

<p>Herriot Tabuteau, CEO and Director of Axsome Therapeutics Inc., reported the disposal of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system, with Ref. ID: 0001193125-25-308354, dated December 04, 2025.</p>

Axsome Therapeutics CEO Herriot Tabuteau Reports Disposal of Common Shares